Molecular glue degraders (MGDs) are small molecules that degrade proteins of interest via the ubiquitin−proteasome system. WhileMGDs were historically discovered serendipitously, approaches for MGD discovery now include cell-viability-based drug screens or data mining of public transcriptomics and drug response datasets. These approaches, however, have target spaces restricted to the essential proteins. Here we develop a high-throughput workflow for MGD discovery that also reaches the nonessential proteome. This workflow begins with the rapid synthesis of a compound library by sulfur(VI) fluoride exchange chemistry coupled to a morphological profiling assay in isogenic cell lines thatvary in levels of the E3 ligase CRBN. By comparing the morphological changes induced by compound treatment across the isogeniccell lines, we were able to identify FL2-14 as a CRBN-dependent MGD targeting the nonessential protein GSPT2. We envision thatthis workflow would contribute to the discovery and characterization of MGDs that target a wider range of proteins.
SLAS GLOBAL HEADQUARTERS1301 West 22nd Street, Suite 708Oak Brook, IL 60523 USA
Phone+1.630.256.7527
JoinGive Back
About UsTerms of Use